Skip to main content

BOOTHBAY FUND MANAGEMENT, LLC

Position in CYTK — Cytokinetics Inc

CIK 1549230 NEW YORK, NY

Position in CYTK

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$5,800,757
-$1,083,212 QoQ
Shares Held
68,092
-34.8% QoQ
Ownership
0.049%
of shares outstanding
% of Portfolio
0.12%
of 13F equity value
Holder Rank
#156
of 480 holders
Holding Since
Dec 2020
18 quarters on record
Voting authority Sole 0% Shared 100% None 0%

Common Shares in CYTK Over Time

Shares Held

Position Value (USD)

Derivatives in CYTK

reported options exposure · as of Mar 31, 2026
CallValue
$9,991,956
CallShares
151,600
PutValue
$10,565,373
PutShares
160,300

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

BOOTHBAY FUND MANAGEMENT, LLC holds $665,103,201 across 158 Biotechnology names. CYTK ranks #23 (0.9% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in CYTK

Export CSV
27 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $5,800,757 68,092
2026-03-31 $6,883,969 104,445
2026-03-31 $10,565,373 160,300
2026-03-31 $9,991,956 151,600
2025-12-31 $3,587,023 56,453
2025-12-31 $5,254,758 82,700
2025-09-30 $5,046,207 91,816
2025-09-30 $2,396,256 43,600
2025-06-30 $1,770,944 53,600
2025-06-30 $2,702,539 81,796
2025-03-31 $3,303,618 82,200
2024-12-31 $3,921,724 83,370
2024-09-30 $4,789,857 90,717
2024-09-30 $807,840 15,300
2024-06-30 $5,033,322 92,900
2024-03-31 $6,722,076 95,879
2024-03-31 $1,871,937 26,700
2023-12-31 $3,567,694 42,732
2023-12-31 $16,030,080 192,000
2023-09-30 $1,219,644 41,400
2023-09-30 $1,219,644 41,400
2023-03-31 $417,423 11,862
2022-09-30 $5,058,180 104,400
2022-06-30 $344,258 8,762
2021-06-30 $241,774 12,217
2021-03-31 $298,495 12,833
2020-12-31 $476,610 22,936